Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Conducting QA Audits in Ointment Manufacturing – V 2.0

Posted on By

SOP for Conducting QA Audits in Ointment Manufacturing – V 2.0

Procedure for Conducting QA Audits in Ointment Manufacturing

Department Quality Assurance (QA)/Compliance
SOP No. SOP/Ointment/087
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a systematic approach for conducting Quality Assurance (QA) audits in ointment manufacturing. The QA audit ensures compliance with Good Manufacturing Practices (GMP), regulatory requirements, and internal quality standards.

2. Scope

This SOP applies to all personnel in the Quality Assurance (QA) and Compliance departments responsible for conducting internal and external audits of ointment manufacturing processes, facilities, equipment, and documentation.

3. Responsibilities

  • QA Auditor: Conducts audits, identifies non-conformances, and prepares audit reports.
  • Production Manager: Ensures manufacturing processes comply with GMP requirements.
  • Quality Control (QC) Analyst: Supports QA audits by providing testing and laboratory documentation.
  • Compliance Officer: Ensures regulatory requirements are met and oversees corrective actions.
  • QA Manager: Reviews audit findings, approves reports, and monitors implementation of corrective actions.
See also  Ointments: SOP for Addressing Deviations in Dispensed Quantities - V 2.0

4. Accountability

The QA Manager and Compliance Officer are accountable for ensuring that QA audits are conducted as per GMP and regulatory guidelines.

5. Procedure

5.1 Audit Planning

  • Define the scope and objectives of the QA audit.
  • Prepare an annual audit schedule covering all critical manufacturing processes.
  • Identify audit criteria based on
GMP regulations and company policies.
  • Ensure that the audit team is trained and qualified.
  • 5.2 Conducting the Audit

    5.2.1 Facility and Equipment Inspection

    • Verify that manufacturing areas comply with GMP cleanliness and safety standards.
    • Check calibration and maintenance records of production equipment.
    • Ensure that raw materials and finished products are stored as per defined conditions.

    5.2.2 Process Compliance Audit

    • Observe the adherence to standard operating procedures (SOPs).
    • Review batch manufacturing records for completeness and accuracy.
    • Verify in-process quality control checks and test result documentation.

    5.2.3 Documentation and Record Review

    • Ensure batch manufacturing records (BMR) and batch packaging records (BPR) are complete.
    • Verify deviation reports and corrective actions taken.
    • Ensure compliance with change control procedures.

    5.2.4 Personnel Training and Hygiene

    • Check that manufacturing personnel are trained as per regulatory requirements.
    • Ensure hygiene and protective clothing standards are maintained.
    • Verify documentation of training records.

    5.3 Identifying Non-Conformances

    • Classify audit findings into:
      • Critical: Issues affecting patient safety or regulatory compliance.
      • Major: Non-conformances that may impact product quality.
      • Minor: Issues that require procedural improvements.
    • Document all observations in the QA Audit Report.

    5.4 Corrective and Preventive Actions (CAPA)

    • Discuss audit findings with relevant department heads.
    • Develop a Corrective and Preventive Action (CAPA) plan.
    • Ensure that corrective actions address the root cause of non-conformances.
    • Set timelines for implementing corrective measures.

    5.5 Follow-Up and Audit Closure

    • Perform a follow-up audit to verify corrective actions have been implemented.
    • Close the audit once all non-conformances have been resolved.
    • Ensure that audit records are stored for regulatory review.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • CAPA – Corrective and Preventive Action
    • BMR – Batch Manufacturing Record
    • BPR – Batch Packaging Record

    7. Documents

    • QA Audit Checklist (Annexure-1)
    • QA Audit Report (Annexure-2)

    8. References

    • WHO GMP Guidelines for Pharmaceutical Manufacturing
    • ICH Q9 – Quality Risk Management
    • ICH Q10 – Pharmaceutical Quality System

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: QA Audit Checklist

    Audit Area Checklist Item Compliant (Yes/No) Remarks
    Facility Manufacturing area cleanliness Yes Compliant
    Equipment Calibration records available Yes Compliant
    Documentation BMR and BPR records complete No Missing entries

    Annexure-2: QA Audit Report

    Date Audit Location Audit Findings Non-Conformance Level Corrective Action Status
    01/02/2025 Ointment Manufacturing Area Incomplete batch records Major Re-train operators Open
    02/02/2025 Filling Line Equipment calibration overdue Critical Immediate recalibration Closed

    12. Revision History:

    See also  Ointments: SOP for Handling Deviations in Ointment Manufacturing - V 2.0
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: Tablets: SOP for Particle Size Analysis in Slow-Release Tablets – V 2.0
    Next Post: Aerosol: SOP for Documentation of Development Batch Records – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version